{
  "abstract": "Despite their physical resilience and peak performances, athletes are at a significant risk of mental health conditions. Symptoms of anxiety and depression can affect 30%–40% of elite athletes,1–3 while up to 8% of all athletes are affected by the neurodevelopmental condition attention-deficit hyperactivity disorder (ADHD).4 Established interventions to manage and alleviate symptoms of mental health and neurodevelopmental conditions include psychological therapies, lifestyle and social interventions and pharmacological treatments.",
  "authors": [
    {
      "affiliations": [
        "Exercise and Sport Science, Charles Darwin University, Darwin, Northern Territory, Australia"
      ],
      "name": "Tyler T Henderson"
    },
    {
      "affiliations": [
        "Centre for Sensorimotor Performance, School of Human Movement and Nutrition Sciences, The University of Queensland, Brisbane, Queensland, Australia"
      ],
      "name": "Lucas B R Orssatto"
    },
    {
      "affiliations": [
        "Faculty of Health Sciences and Medicine, Bond University, City of Gold Coast, Queensland, Australia"
      ],
      "name": "Jacob R Thorstensen"
    }
  ],
  "title": "Make or break: psychotropic medications have off-label effects on neuromuscular performance",
  "uid": "99a23653-b4b3-5f30-a82f-3e5dcc76e5ad"
}